Cancer of Larynx

Accurate staging is crucial for laryngeal cancer management. The current gold standard is the 8th edition of the American Joint Committee on Cancer (AJCC) TNM staging system, which incorporates tumor size (T), lymph node involvement (N), and distant metastasis (M). This system provides a detailed classification allowing for personalized treatment strategies and prognostication. Beyond the AJCC, clinicians should consider incorporating imaging findings from CT and MRI scans, and in specific cases, PET scans, for more precise T and N staging. Explore how integrating these imaging modalities can refine your laryngeal cancer staging process and lead to improved patient outcomes. Consider implementing a multidisciplinary tumor board review to discuss complex cases and ensure consensus on staging and treatment.

Differentiating laryngeal cancer from benign conditions like laryngitis or vocal cord nodules can be challenging, especially in early stages where hoarseness is a common symptom. Persistent hoarseness lasting longer than two weeks warrants further investigation. While laryngitis often resolves within this timeframe, laryngeal cancer symptoms tend to persist and may be accompanied by other signs like dysphagia, odynophagia, hemoptysis, referred otalgia, or a neck mass. A thorough clinical examination, including fiberoptic laryngoscopy, is essential for visualization of the larynx. If any suspicion remains, a biopsy is mandatory for definitive diagnosis. Learn more about the subtle clinical clues that can help distinguish laryngeal cancer from benign laryngeal conditions and consider implementing standardized diagnostic pathways in your practice to ensure timely cancer detection.

Transoral laser surgery (TLS) has revolutionized the treatment of early-stage laryngeal cancer (T1-T2), offering minimally invasive resection with excellent functional outcomes, particularly voice preservation. Advancements such as narrow-band imaging and CO2 laser technology allow for precise tumor removal while minimizing damage to surrounding healthy tissue. TLS is often preferred for early-stage glottic cancers where preserving vocal function is a primary concern. However, for more advanced T3-T4 lesions, open laryngectomy with or without adjuvant radiation therapy or chemoradiation may be necessary to achieve complete tumor eradication. The choice between TLS, open surgery, and radiation therapy depends on various factors, including tumor stage, location, patient comorbidities, and individual preferences. Consider implementing a multidisciplinary approach, involving an otolaryngologist, radiation oncologist, and medical oncologist, to determine the optimal treatment strategy for each patient. Explore how recent advancements in TLS are expanding its applications and improving outcomes in laryngeal cancer care.